News Quantified

ETON – eton pharmaceuticals, inc. (US:NASDAQ)

How The Hemangeol Deal Is Reframing The Eton Pharmaceuticals (ETON) Investment Story [Yahoo! Finance]

4/16

06:50 am

eton

Medium

Eton Pharmaceuticals Announces CFO Succession Plan

How The Eton Pharmaceuticals (ETON) Story Is Shifting With Hemangeol And New Valuation Targets [Yahoo! Finance]

Eton Pharmaceuticals (ETON) was upgraded by Zacks Research from "hold" to "strong-buy".

Eton Pharmaceuticals (ETON) had its price target raised by HC Wainwright from $37.00 to $52.00. They now have a "buy" rating on the stock.

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}